Vertex Pharmaceuticals, Inc. (VRTX)
466.10
-3.24
(-0.69%)
USD |
NASDAQ |
Mar 16, 16:00
466.60
+0.50
(+0.11%)
After-Hours: 20:00
Vertex Pharmaceuticals Profit Margin (Quarterly) : 36.91% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 27.44% |
| Moderna, Inc. | -121.8% |
| Amgen, Inc. | 13.47% |
| Pfizer Inc. | -9.34% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.97% |
| Return on Assets | 16.33% |
| Return on Invested Capital | 20.84% |
| Gross Profit Margin (Quarterly) | 85.56% |
| Operating Margin (Quarterly) | 40.30% |
| Return on Net Operating Assets | 50.87% |